Skip to main content

Advertisement

Log in

A case of Hodgkin lymphoma-type Richter syndrome presenting as small-intestinal perforation

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Hodgkin lymphoma type of Richter syndrome (HL-type RS) is a rare disease that arises in patients with chronic lymphocytic leukemia (CLL). HL-type RS lesions can manifest in various sites and are often accompanied by related symptoms. This is the first case report to describe diagnosis of HL-type RS after emergency surgery for gastrointestinal perforation caused by the development of a HL-type RS lesion. A 47-year-old man diagnosed with CLL three years prior began treatment with ibrutinib due to worsening anemia and splenomegaly two months prior to the emergency department presentation. Although splenomegaly improved, lymphocytopenia, anemia, and a newly arising mesenteric lymphadenopathy continued to worsen. He presented to the emergency department with abdominal pain, and subsequent surgery revealed small intestinal perforation and mesenteric lymphadenopathy with HL-type RS confirmed by histopathological examination of the resected small intestine. He subsequently received brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A + AVD), which effectively managed the HL-type RS. If CLL clinical presentation deviates from the typical course, an early tissue biopsy should be considered to evaluate for HL-type RS. Given the adoption of the A + AVD regimen as the standard treatment for Hodgkin lymphoma, further research is needed to evaluate its efficacy in HL-type RS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Rossi D, Spina V, Gaidano G. Biology and treatment of Richter syndrome. Blood. 2018;131:2761–72.

    Article  CAS  PubMed  Google Scholar 

  2. Tadmor T, Levy I. Richter transformation in chronic lymphocytic leukemia: update in the era of novel agents. Cancers. 2021. https://doi.org/10.3390/cancers13205141.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Sigmund AM, Kittai AS. Richter’s transformation. Curr Oncol Rep. 2022;24:1081–90.

    Article  PubMed  Google Scholar 

  4. Xiao W, Chen WW, Sorbara L, Davies-Hill T, Pittaluga S, Raffeld M, et al. Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion. Hum Pathol. 2016;55:108–16.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kaźmierczak M, Kroll-Balcerzak R, Balcerzak A, Czechowska E, Gil L, Sawiński K, et al. Hodgkin lymphoma transformation of chronic lymphocytic leukemia: cases report and discussion. Med Oncol. 2014;31:800.

    Article  PubMed  Google Scholar 

  6. Reddy N, Thompson-Arildsen MA. Hodgkin’s lymphoma: Richter’s transformation of chronic lymphocytic leukemia involving the liver. J Clin Oncol. 2010;28:e543–4.

    Article  PubMed  Google Scholar 

  7. Tsimberidou A-M, O’Brien S, Kantarjian HM, Koller C, Hagemeister FB, Fayad L, et al. Hodgkin transformation of chronic lymphocytic leukemia: the M D Anderson Cancer Center experience. Cancer. 2006;107:1294–302.

    Article  CAS  PubMed  Google Scholar 

  8. Almhanna K, Wongchaowart N, Sweetenham J. Intracerebral Hodgkin’s lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma: a case report and literature review. Cancer Invest. 2009;27:215–20.

    Article  PubMed  Google Scholar 

  9. Zhu K, Jamroz A, Huang S, Villa D, Freeman CL, Scott DW, et al. Outcomes of Hodgkin variant Richter transformation in chronic lymphocytic leukaemia and small lymphocytic lymphoma in British Columbia. Br J Haematol. 2022;198:684–92.

    Article  CAS  PubMed  Google Scholar 

  10. Parikh SA, Habermann TM, Chaffee KG, Call TG, Ding W, Leis JF, et al. Hodgkin transformation of chronic lymphocytic leukemia: incidence, outcomes, and comparison to de novo Hodgkin lymphoma. Am J Hematol. 2015;90:334–8.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Bockorny B, Codreanu I, Dasanu CA. Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature. Br J Haematol. 2012;156:50–66.

    Article  PubMed  Google Scholar 

  12. Petrackova A, Turcsanyi P, Papajik T, Kriegova E. Revisiting Richter transformation in the era of novel CLL agents. Blood Rev. 2021;49: 100824.

    Article  CAS  PubMed  Google Scholar 

  13. Döhner H, Stilgenbauer S, Benner A, Leupolt E, Kröber A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343:1910–6.

    Article  PubMed  Google Scholar 

  14. Khalid K, Padda J, Syam M, Moosa A, Kakani V, Sanka S, et al. 13q14 deletion and its effect on prognosis of chronic lymphocytic leukemia. Cureus. 2021;13: e16839.

    PubMed  PubMed Central  Google Scholar 

  15. King RL, Gupta A, Kurtin PJ, Ding W, Call TG, Rabe KG, et al. Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter? Blood Cancer J. 2022;12:18.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, et al. Brentuximab Vedotin with chemotherapy for Stage III or IV Hodgkin’s Lymphoma. N Engl J Med. 2018;378:331–44.

    Article  CAS  PubMed  Google Scholar 

  17. Ansell SM, Radford J, Connors JM, Długosz-Danecka M, Kim W-S, Gallamini A, et al. Overall survival with brentuximab vedotin in stage III or IV Hodgkin’s lymphoma. N Engl J Med. 2022;387:310–20.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kosuke Miki.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miki, K., Ogasawara, R., Sugimura, S. et al. A case of Hodgkin lymphoma-type Richter syndrome presenting as small-intestinal perforation. Int J Hematol 118, 766–771 (2023). https://doi.org/10.1007/s12185-023-03655-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-023-03655-2

Keywords

Navigation